Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akila Viswanathan

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|October 20, 2021
Establishing a Deaf and American Sign Language Inclusive Residency ProgramColin Hill, Curtiland Deville, Ana Kiess, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 28, 2020
Race-driven survival differential in women diagnosed with endometrial cancers in the USAZachary D Horne, Solomiya R Teterichko, Scott M Glaser, et al.
Cancers|March 28, 2024
Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer TreatmentMichele Moreau, Lensa S Keno, Debarghya China, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2016
Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global ScaleDavid Gaffney, Bill Small, Henry Kitchener, et al.
Practical Radiation Oncology|October 4, 2015
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenariosKaren Lim, Beth Erickson, Ina M Jürgenliemk-Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2019
Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor TherapyYoungran Park, M Herman Chui, Yohan Suryo Rahmanto, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancerKaren Lim, William Small, Lorraine Portelance, et al.
JAMA Oncology|February 26, 2016
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and VulvaBrooke E Howitt, Heather H Sun, Margaretha G M Roemer, et al.
Gynecologic Oncology|October 16, 2021
Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538]Kimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Gynecologic Oncology|July 4, 2021
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Academic Medicine : Journal of the Association of American Medical Colleges|October 20, 2021
Establishing a Deaf and American Sign Language Inclusive Residency ProgramColin Hill, Curtiland Deville, Ana Kiess, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 28, 2020
Race-driven survival differential in women diagnosed with endometrial cancers in the USAZachary D Horne, Solomiya R Teterichko, Scott M Glaser, et al.
Cancers|March 28, 2024
Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer TreatmentMichele Moreau, Lensa S Keno, Debarghya China, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2016
Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global ScaleDavid Gaffney, Bill Small, Henry Kitchener, et al.
Practical Radiation Oncology|October 4, 2015
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenariosKaren Lim, Beth Erickson, Ina M Jürgenliemk-Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2019
Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor TherapyYoungran Park, M Herman Chui, Yohan Suryo Rahmanto, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancerKaren Lim, William Small, Lorraine Portelance, et al.
JAMA Oncology|February 26, 2016
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and VulvaBrooke E Howitt, Heather H Sun, Margaretha G M Roemer, et al.
Gynecologic Oncology|October 16, 2021
Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538]Kimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Gynecologic Oncology|July 4, 2021
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Pageof 4